Bioventix Income Statement

Financials in millions GBP. Fiscal year is July - June.

Millions GBP. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Revenue	12.54	13.12	13.61	12.82	11.72	10.93
Revenue Growth (YoY)	-8.21%	-3.61%	6.17%	9.36%	7.22%	5.98%
Cost of Revenue	0.95	1.2	0.93	0.83	0.71	0.82
Gross Profit	11.59	11.92	12.68	11.99	11.01	10.11
Selling, General & Admin	2.02	2.05	1.99	1.77	1.61	1.51
Other Operating Expenses	-0.17	-0.04	0.1	0.19	0.13	0.52
Total Operating Expenses	1.85	2.01	2.1	1.95	1.74	2.03
Operating Income	9.75	9.9	10.58	10.03	9.27	8.09
Interest Income	0.16	0.19	0.2	0.1	0	0.03
Interest Expense	-	-	-	-	-0	-
Other Non-Operating Income (Expense)	-	-	-0.18	-	-	-
Total Non-Operating Income (Expense)	0.16	0.19	0.02	0.1	0	0.03
Pretax Income	9.9	10.1	10.6	10.13	9.28	8.12
Provision for Income Taxes	2.46	2.51	2.51	1.76	1.6	1.39
Net Income	7.44	7.58	8.1	8.37	7.67	6.73
Net Income to Common	7.44	7.58	8.1	8.37	7.67	6.73
Net Income Growth	-5.21%	-6.33%	-3.29%	9.10%	14.01%	-6.54%
Shares Outstanding (Basic)	5	5	5	5	5	5
Shares Outstanding (Diluted)	5	5	5	5	5	5
Shares Change (YoY)	-0.08%	-0.08%	0.14%	0.56%	-0.03%	0.75%
EPS (Basic)	1.42	1.45	1.55	1.61	1.47	1.29
EPS (Diluted)	1.41	1.43	1.53	1.58	1.46	1.28
EPS Growth	-5.13%	-6.26%	-3.42%	8.48%	14.04%	-7.24%
EBIT	9.75	9.9	10.58	10.03	9.27	8.09